iPSC Differentiation - Definigen

IPSC Differentiation

Differentiation of disease-specific human iPSC libraries into a range of human cell types

Overview

DefiniGEN’s core technology platform has focussed on the development of differentiation protocols which increases the success of generating viable, functional and mature hepatocytes from either patient material (generally fibroblasts and PBMCs) or existing iPSC lines.

petri dish under microscope

Why choose DefiniGEN?

Our scientific team have optimized differentiation protocols for endodermal cell types across hundreds of different donor lines, both wild-type and diseased, and have established a best-in-class methodology for maximizing the chances of successful differentiation.